文献速递真菌感染细菌感染、耐药与抗菌药物

前唑类时代血液恶性肿瘤患者真菌感染:医学真菌学新纪元的黎明

Fungal infections in patients with haematological malignancies in the pre-triazole era: the dawn of a new era in medical mycology.
PubMed 文献 · Clin Microbiol Infect · 2025-06-09

本文回顾了三唑类问世前血液恶性肿瘤患者侵袭性真菌感染(IFI)的关键诊疗里程碑。尸检研究确认念珠菌、曲霉和毛霉目重要性,CT与半乳甘露聚糖试验改善早期诊断,持续中性粒细胞减少性发热经验性两性霉素B试验使死亡率减半。唑类时代从酮康唑起步,经伊曲康唑和氟康唑拓宽预防但筛选出罕见霉菌和耐药酵母,推动新型三唑类和棘白菌素及风险适应预防策略发展。

要点

  • 尸检研究确认念珠菌、曲霉和毛霉目为重要病原, prolonged neutropenia和糖皮质激素与感染风险增高相关。
  • CT和早期半乳甘露聚糖试验改善早期诊断,持续中性粒细胞减少性发热经验性两性霉素B试验使死亡率减半。
  • 唑类预防拓宽但筛选出罕见霉菌和耐药酵母,驱动新型三唑类、棘白菌素及风险适应预防策略发展。

核心结论

  • 宿主免疫仍是IFI风险和结局的首要决定因素,及时敏感的诊断可挽救生命,抗真菌药物管理须预见真菌耐药演变。

研究设计与样本

  • 综述,检索尸检系列、临床试验、药理学研究和历史评论,并辅以化疗、造血细胞移植和抗真菌药物开发的 seminal reviews。

主要发现

  • 尸检研究确认念珠菌、曲霉和毛霉目重要性,并将 prolonged neutropenia 和糖皮质激素与感染风险增高相关联。
  • CT和早期半乳甘露聚糖试验改善早期诊断,持续中性粒细胞减少性发热经验性两性霉素B试验使死亡率减半。
  • 辅助策略包括保护性环境、肠道去污染、细胞因子治疗和粒细胞输注,常受成本、毒性或获益不确定限制。
  • 唑类时代从酮康唑开始,进展至伊曲康唑和氟康唑,拓宽预防但筛选出罕见霉菌和耐药酵母。

临床怎么用

  • 宿主免疫是IFI风险和结局的首要决定因素。
  • 及时、敏感的 diagnostics 可挽救生命。
  • 抗真菌药物管理须预见真菌耐药的演变。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opportunistic invasive fungal infections (IFIs) emerged as common causes of death of patients with haematological malignancies (HM) once effective antibacterial therapy reduced bacterial deaths. In the dawn of medical mycology, timely diagnosis was difficult, and treatment was limited by the toxicity of antifungals and associated with poor outcomes. OBJECTIVES: This study aims to chronicle key diagnostic and therapeutic milestones before triazoles and show how they forged the foundations of modern mycology practice in HM. SOURCES: Autopsy series, clinical trials, pharmacological studies, and historical commentaries augmented by seminal reviews on chemotherapy, haematopoietic cell transplantation and antifungal development. CONTENT: Autopsy studies identified the importance of Candida, Aspergillus and Mucorales and linked prolonged neutropenia and corticosteroids to heightened risk of infection. Computed tomography and early galactomannan assays improved early diagnosis, whereas trials of empirical amphotericin B in persistent neutropenic fever halved mortality. Adjunctive strategies, including protected environments, gut decontamination, cytokine therapy and granulocyte transfusions, were often constrained by cost, toxicity, or uncertain benefit. Historically, the azole era began with ketoconazole and progressed to itraconazole and fluconazole, broadening prophylaxis but selecting for rare moulds and resistant yeasts. These pressures drove the development of potent newer triazoles and echinocandins and introduced risk-adapted prophylactic strategies. IMPLICATIONS: Lessons from the pre-triazole era endure: host immunity remains the prime determinant of IFI risk and outcome; timely, sensitive diagnostics are lifesaving; and antifungal stewardship must anticipate the evolution of fungal resistance. As novel chemotherapeutics, cellular therapies, and resistant pathogens reshape IFI epidemiology in HM, continuous innovations in diagnostics, antifungals, and immunomodulatory approaches remain essential.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Akova U, Hicklen R, Lewis RE, et al. Fungal infections in patients with haematological malignancies in the pre-triazole era: the dawn of a new era in medical mycology. Clin Microbiol Infect. 2025. PMID: 40499653. doi:10.1016/j.cmi.2025.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。